JW LIFESCIENCE CORPORATION

234080 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩11,000.00
-0.18%
Delayed · cached 15 min

Fair value analysis

234080
JW LIFESCIENCE CORPORATION
PharmaceuticalsPharmaceuticals
₩11,000.00
Close used for this calculation
₩26,875.83Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
71/100
Profitability13/25
Returns18/25
Balance Sheet15/25
Efficiency25/25
Growth14/25
Strong
Quality radar
71Prof.13/25Ret.18/25Eff.25/25B.Sht15/25Growth14/25

Consensus fair value

₩26,875.83
Below FV
▲ +144.3% against the close used
Model range ₩8,348.44 – ₩43,195.17
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩8,348.44Fair value₩26,875.83Bull₩43,195.17
FairClose
52-week traded range
52W low ₩10,720.0052W high ₩15,500.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

JW LIFESCIENCE CORPORATION closed at ₩11,000.00, 59.1% below the consensus fair value of ₩26,875.83 drawn from 10 valuation models.

Financial DNA score 71/100 — Strong. P/E of 6.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩27,718.29
+152.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=4.5%, r=10%, tg=3%, n=10yr
Graham Number
₩24,365.52
+121.5%
√(22.5 × EPS × BVPS)
EPS=1847, BVPS=14285.71
Graham Formula
₩43,195.17
+292.7%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=4.5%, FD=3.3%
P/E Fair Value
₩36,940.00
+235.8%
EPS × 20x (sector P/E)
EPS=1847, Sector P/E=20x
Peter Lynch (PEG)
₩8,348.44
-24.1%
EPS × Growth% (PEG = 1 is fair)
EPS=1847, g=4.5%
EV/EBITDA
₩23,156.15
+110.5%
(EBITDA × 12.3x − Net Debt) ÷ Shares
EBITDA=33.24B
Dividend Discount (DDM)
₩9,231.33
-16.1%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=484, r=10%, g=4.5%
Book Value (P/B)
₩22,028.15
+100.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=14285.71, ROE=13%, g=4.5%, r=10%
Reverse DCF
₩11,000.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -9.8% | Historical: 4.5%
Margin of Safety
₩24,791.06
+125.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=33054.74, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.